Home Details
| Official Symbol of Gene | GAPDH |
| Species | Homo sapiens |
| Entrez Gene ID | 2597 |
| Official Full Name | glyceraldehyde-3-phosphate dehydrogenase |
| Also known as | G3PD; GAPD; HEL-S-162eP |
| Gene Type | protein coding |
| dbXrefs | Ensembl:ENSG00000111640 MIM:138400; AllianceGenome:HGNC:4141 |
| Map Location | 12p13.31 |
| Detected Sample | blood |
| Sample Detail | N/A |
| Detected Method | qc-PCR |
| Disease | MS |
| Disease subtype | RRMS |
| Population | N/A |
| Sample Size | 92 IFNβ-treated MS patients / 99 MS patients never treated with IFNβ or other immunosuppressive therapy (treatment-nave patients) and 17 healthy volunteers |
| Pubmed ID | 12601105 |
| Year | 2003 |
| Title | Persistent neutralizing antibodies abolish the interferon beta bioavailability in MS patients |
| Expression | down-regulation |
| Risk type | Disease risk |
| Result | A comparison of MxA mRNA levels in healthy volunteers and treatment-nave patients with MS showed that MxA expression was comparable between the two groups of subjects.In these patients, MxA gene expression was low, but always detectable. |
| Mechanism/Pathway | N/A |

2023,CopyRight © HMU. College of Bioinformatics Science and Technology, Harbin, China.